Literature DB >> 1346538

Diagnostic criteria for polyarteritis nodosa in childhood.

S Ozen1, N Besbas, U Saatci, A Bakkaloglu.   

Abstract

Clinical and laboratory features of 31 children with a diagnosis of polyarteritis nodosa were evaluated retrospectively. All the patients had musculoskeletal involvement, renal involvement, or both during the course of the disease. We have defined involvement of these two systems as the major diagnostic criteria in polyarteritis nodosa. Ten additional minor criteria were defined: (1) cutaneous findings, (2) gastrointestinal involvement, (3) peripheral neuropathy, (4) central nervous system involvement, (5) hypertension, (6) cardiac involvement, (7) lung involvement, (8) constitutional symptoms, (9) presence of acute-phase reactants, and (10) presence of hepatitis B surface antigen. We propose that the presence of five of these criteria, including at least one major criterion, is highly suggestive of polyarteritis nodosa; such a combination was present in 97% of our patients. Fourteen of the patients were treated with corticosteroids alone and 14 were treated with a combination of steroids plus cyclophosphamide or azathioprine. At the last follow-up examination six patients in the steroid group and nine in the combination group were considered to have complete remission of disease or inactive disease with persisting symptoms in an organ system. The overall mortality rate was 16%; renal involvement had the greatest adverse effect on outcome. We suggest that in patients with five of the 12 diagnostic criteria, especially those with renal involvement, therapy should be initiated promptly while diagnostic procedures are being carried out.

Entities:  

Mesh:

Year:  1992        PMID: 1346538     DOI: 10.1016/s0022-3476(05)80428-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Intestinal perforation due to polyarteritis nodosa.

Authors:  A Chattopadhyay
Journal:  Indian J Pediatr       Date:  2001-03       Impact factor: 1.967

Review 2.  Vasculitis in children.

Authors:  L Kumar; S Singh
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

3.  A new international classification of childhood vasculitis.

Authors:  Michael J Dillon; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2006-07-04       Impact factor: 3.714

4.  EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides.

Authors:  S Ozen; N Ruperto; M J Dillon; A Bagga; K Barron; J C Davin; T Kawasaki; C Lindsley; R E Petty; A M Prieur; A Ravelli; P Woo
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

5.  Abdominal manifestations of polyarteritis nodosa demonstrated with CT.

Authors:  Ibrahim Adaletli; Yigit Ozpeynirci; Sebuh Kurugoglu; Lale Sever; Nil Arisoy
Journal:  Pediatr Radiol       Date:  2010-02-12

6.  The coexistence of familial Mediterranean fever and polyarteritis nodosa; report of a case.

Authors:  H Koçak; N Cakar; B Hekimoglu; C Atakan; N Akkök; S Unal
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

7.  Clinical quiz. Polyarteritis nodosa (PAN).

Authors:  D S Fitzwater; R J Wyatt; R W Chesney
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

Review 8.  The changing face of polyarteritis nodosa and necrotizing vasculitis.

Authors:  Seza Ozen
Journal:  Nat Rev Rheumatol       Date:  2017-05-11       Impact factor: 20.543

Review 9.  Problems in classifying vasculitis in children.

Authors:  Seza Ozen
Journal:  Pediatr Nephrol       Date:  2005-05-07       Impact factor: 3.714

10.  Childhood vasculitides in Turkey: a nationwide survey.

Authors:  Seza Ozen; Aysin Bakkaloglu; Ruhan Dusunsel; Oguz Soylemezoglu; Fatih Ozaltin; Hakan Poyrazoglu; Ozgur Kasapcopur; Ozan Ozkaya; Fatos Yalcinkaya; Ayse Balat; Nurdan Kural; Osman Donmez; Harika Alpay; Ali Anarat; Sevgi Mir; Ayfer Gur-Guven; Ferah Sonmez; Faysal Gok
Journal:  Clin Rheumatol       Date:  2006-04-04       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.